The system is designed to enhance the precision of lung nodule biopsies, potentially leading to earlier-stage cancer detection.
Patients can activate the Revi implant at their convenience using a lightweight wireless wearable placed around the ankle.
Developed in collaboration with Trillium Health, the aPAP ClearPath test is a simple, cost-free and non-invasive immunoassay.
The enhanced device now permits a maximum of six cartridges per day, up from two.
The assay utilises a qPCR reaction to measure the methylation levels of three DNA biomarkers specific to urothelial cancer.
Give your business an edge with our leading industry insights.
The Momentum systems are designed for stabilisation, fixation, and correction of the thoracolumbar and sacroiliac spine.
The company plans to enrol up to 30 patients in the study, with regular evaluations to further assess the treatment’s safety.
The panel utilises precise liquid chromatography combined with advanced tandem mass spectrometry testing to detect misuse of NPS.
The system includes a series of removable devices that are arranged in small increments of movement.
The transaction is expected to be completed in the first quarter of next year.